Provention bio puts type 1 diabetes to the test with pledge campaign for diabetes awareness month

Red bank, n.j., nov. 9, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced it's putting type 1 diabetes (t1d) to the test during diabetes awareness month this november.
PRVB Ratings Summary
PRVB Quant Ranking